On Thursday, 2 February, the Pharmaceutical Group of the European Union (PGEU) published a number of recommendations to tackle the shortage of medicines. It tackles in turn all the different problems of access to data and responsiveness by the health authorities.
The PGEU indicates that, “Evidence suggests it is an increasing problem across the European Union, having a significant impact on patients, on health professionals, on healthcare systems and suppliers”. The PGEU represents...